Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Amoxapine, sold under the brand name Asendin among others, is a tricyclic antidepressant (TCA). It is the N-demethylated metabolite of loxapine. Amoxapine first received marketing approval in the United States in 1980, approximately 10 to 20 years after most of the other TCAs were introduced in the United States.
Community, Culture, Applications & Measurement
Explore the main themes, entities and connections around Amoxapine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
effects blood also treatment adverse life-threatening metabolite side brand asendin 10 names breast incidence include body less often receptor tcas
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Amoxapine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Amoxapine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Amoxapine | ATC code | N06AA17 (WHO) | 1.00 | infobox |
| Amoxapine | Bioavailability | >60% | 1.00 | infobox |
| Amoxapine | CAS Number | 14028-44-5 Y | 1.00 | infobox |
| Amoxapine | ChEBI | CHEBI:2675 Y | 1.00 | infobox |
| Amoxapine | ChEMBL | ChEMBL1113 Y | 1.00 | infobox |
| Amoxapine | ChemSpider | 2085 Y | 1.00 | infobox |
| Amoxapine | CompTox Dashboard (EPA) | DTXSID7022598 | 1.00 | infobox |
| Amoxapine | DrugBank | DB00543 Y | 1.00 | infobox |
| Amoxapine | ECHA InfoCard | 100.034.411 | 1.00 | infobox |
| Amoxapine | Elimination half-life | 8–10 hours (30 hours for chief active metabolite) | 1.00 | infobox |
| Amoxapine | Excretion | Renal (60%), feces (18%) | 1.00 | infobox |
| Amoxapine | Formula | C17H16ClN3O | 1.00 | infobox |
| Amoxapine | IUPHAR/BPS | 201 | 1.00 | infobox |
| Amoxapine | KEGG | D00228 Y | 1.00 | infobox |
| Amoxapine | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Amoxapine | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Amoxapine | Legal status | US: ℞-only | 1.00 | infobox |
| Amoxapine | License data | US FDA: Amoxapine | 1.00 | infobox |
| Amoxapine | MedlinePlus | a682202 | 1.00 | infobox |
| Amoxapine | Metabolism | Hepatic (cytochrome P450 system) | 1.00 | infobox |
| Amoxapine | Molar mass | 313.79 g·mol−1 | 1.00 | infobox |
| Amoxapine | Pronunciation | A-mox-a-peen | 1.00 | infobox |
| Amoxapine | Protein binding | 90% | 1.00 | infobox |
| Amoxapine | PubChem CID | 2170 | 1.00 | infobox |
| Amoxapine | Routes of administration | Oral | 1.00 | infobox |
| Amoxapine | Trade names | Asendin, others | 1.00 | infobox |
| Amoxapine | UNII | R63VQ857OT | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.